European patent granted for Kyoto Univ. prof's iPSC technology

European patent granted for Kyoto Univ. prof's iPSC technology

KYOTO, Japan - Kyoto University professor Shinya Yamanaka (R) speaks at a press conference at the university in Kyoto on July 11, 2011. The European Patent Office has approved a patent for Yamanaka's technology for creating induced pluripotent stem cells, or iPSCs.

  • Product Code
  • ILEA001160781
  • Registered date
  • 2011/7/11 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2011 Kyodo News
  • Media size
  • 1889 × 1252 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 411.92(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Web Summit 2024 - Day One

    Web Summit 2024 - Day One

    Professor of Economics Emeritus at the University of Massachusetts, William Lazonick, participates in the first day of Web Summit in Lisbon, Portugal, on November 12, 2024. The largest technology conference in the world this year has 71,528 attendees from 153 countries and 3,050 companies, with AI emerging as the most represented industry. (Photo by Rita Franca/NurPhoto)
      Kariko, Weissman win Nobel medicine prize for COVID mRNA vaccine work

      Kariko, Weissman win Nobel medicine prize for COVID mRNA vaccine work

      University of Pennsylvania professor Drew Weissman arrives at the venue of a press conference at the university in Philadelphia, the United States, on Oct. 2, 2023, after being awarded this year's Nobel Prize in physiology or medicine jointly with his Hungarian research partner Katalin Kariko for their work leading to the development of COVID-19 vaccines using a new messenger RNA technology.
        World's 1st transplant of iPS heart muscle tissue

        World's 1st transplant of iPS heart muscle tissue

        Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
          World's 1st transplant of iPS heart muscle tissue

          World's 1st transplant of iPS heart muscle tissue

          Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
            World's 1st transplant of iPS heart muscle tissue

            World's 1st transplant of iPS heart muscle tissue

            Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
              World's 1st transplant of iPS heart muscle tissue

              World's 1st transplant of iPS heart muscle tissue

              Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                World's 1st transplant of iPS heart muscle tissue

                World's 1st transplant of iPS heart muscle tissue

                Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                  World's 1st transplant of iPS heart muscle tissue

                  World's 1st transplant of iPS heart muscle tissue

                  Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                    World's 1st test using iPS cells to treat corneal disease

                    World's 1st test using iPS cells to treat corneal disease

                    Osaka University professor Koji Nishida speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
                      World's 1st test using iPS cells to treat corneal disease

                      World's 1st test using iPS cells to treat corneal disease

                      Osaka University professor Koji Nishida (2nd from R) speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo